Skip to content

Positioning the preterm Infant for Neuroprotection (PIN study)

Optimal head position for the first 72 hours of life: Neuroprotection for the preterm infant? A pilot randomised controlled trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000276156
Acronym
PIN study
Enrollment
60
Registered
2019-02-25
Start date
2019-02-13
Completion date
2021-07-29
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the study is to investigate whether specific positioning of the preterm baby’s head in the first 72 hours of life will reduce brain bleeds and lead to improved developmental outcomes. The first stage is to determine whether this study is acceptable to parents and whether it is possible to recruit preterm babies in the first four hours of life when the delivery is often an emergency situation. We hypothesize that the study will be acceptable to parents and that it will be possible to recruit babies within the four hour time frame. Babies born less than 29 weeks gestation will receive either usual positioning practice for the first 72 hours or the optimal positioning group. For the usual positioning group, there is currently no standard way to position the preterm baby for the first 72 hours. Babies in the optimal positioning group will be placed on a slightly tilted surface, on their back and with their head in the centre, for 72 hours. The head will be placed on a special pillow designed to mould to the baby’s head and keep the position stable during this time. Brain oxygen levels and presence of brain bleeds will be measured.

Interventions

Intervention studied is optimal head positioning practice for preterm infants in the first 72 hours of life in the Neonatal Intensive Care Unit. This is a pilot study to determine the feasibility of a randomised controlled trial in terms of whether the recruitment and consenting process is acceptable to parents and practical within fours of delivery which is frequently an emergency situation. Infants will be nursed on a tilted surface up to 30° (ie. full tilt of Giraffe incubator tray plus pos

Intervention studied is optimal head positioning practice for preterm infants in the first 72 hours of life in the Neonatal Intensive Care Unit. This is a pilot study to determine the feasibility of a randomised controlled trial in terms of whether the recruitment and consenting process is acceptable to parents and practical within fours of delivery which is frequently an emergency situation. Infants will be nursed on a tilted surface up to 30° (ie. full tilt of Giraffe incubator tray plus positioning pillow determined at nurses discretion) and positioned supine with head in midline for the first 72 hours of life. A freestanding patient positioning mould (Z-Flo™ neonatal positioner) will keep the head in a stable and consistent position including supporting the base of the occiput to prevent forward flexion of the head/neck to reduce likelihood of airway obstruction. The positioner has a low friction/shear surface, maximum contouring ability for moulding to accommodate tubing/wires, and zero memory ensuring it does not move once moulded. The infant will be briefly moved to sidelying position with head in neutral midline, every four hours to check skin integrity. A laminated chart will be placed on the crib to remind staff of position for each infant. A checklist will be completed by the nurse at the end of each shift to check head position and probe attached, documentation of any problems encountered and removal of positioner etc. Bedside nurse will report changes in head position for unavoidable medical indications and record duration of changes. Research nurse will conduct compliance audit prior to the study and compliance during the study.

Sponsors

Western Sydney Local Health District
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
0 to 4 Hours
Healthy volunteers
No

Inclusion criteria

1. Gestational age <29 weeks 2. Postnatal age <4 hours 3. Parent consent within 4 hours

Exclusion criteria

1. Exutero transfer 2. Presence of lethal congenital anomalies 3. Serious congenital cardiac disease 4 Pre-existing intraventricular haemorrhage (determined on baseline cranial ultrasound) 5. Parent not consenting for study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026